{"schema_version":"secwatch.filing_event.v1","accession":"0001724521-24-000101","form_type":"8-K","ticker":"RCUS","cik":"0001724521","company_name":"Arcus Biosciences, Inc.","filed_at":"2024-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.750345+00:00","generated_at":"2026-06-01T05:57:02.399420+00:00","sec_items":["5.07","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Arcus Biosciences adopts amended director compensation; annual meeting passes all proposals","bullets":["New non-employee director compensation: $45,000 annual cash retainer; $25,000 extra for Lead Independent Director.","Initial equity award: ~$750,000 grant-date value, 2/3 stock options and 1/3 RSUs, vesting over 3 years.","Annual equity award: ~$400,000 grant-date value, vests fully in 12 months or until next annual meeting.","Annual meeting results: all three Class III directors elected; Ernst & Young ratified; say-on-pay approved."],"urls":{"canonical":"https://secwatch.observer/filing/0001724521-24-000101","json":"https://secwatch.observer/filing/0001724521-24-000101.json","markdown":"https://secwatch.observer/filing/0001724521-24-000101.md","text":"https://secwatch.observer/filing/0001724521-24-000101.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1724521/000172452124000101/0001724521-24-000101-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1724521/000172452124000101/rcus-20240606.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:57:02.399420+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}